MBCOF
Marvel Biosciences Corp

9
Mkt Cap
$6.5M
Volume
2,000.00
52W High
$0.241
52W Low
$0.046
PE Ratio
-3.46
MBCOF Fundamentals
Price
$0.1121
Prev Close
$0.1137
Open
$0.1031
50D MA
$0.137
Beta
0.00
Avg. Volume
19,639.47
EPS (Annual)
-$0.0335
P/B
-2.05
Loading...
Loading...
Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. It develops several patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases, and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The company was founded on August 1, 2018 and is headquartered in Calgary, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Marvel Biosciences Corp?
What is the 52-week high for Marvel Biosciences Corp?
What is the 52-week low for Marvel Biosciences Corp?
What is Marvel Biosciences Corp stock price today?
What was Marvel Biosciences Corp stock price yesterday?
What is the PE ratio of Marvel Biosciences Corp?
What is the Price-to-Book ratio of Marvel Biosciences Corp?
What is the 50-day moving average of Marvel Biosciences Corp?

Latest MBCOF News

View
No MBCOF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.